Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
 

Articles

Bariatric Surgery Supported With Transvalvular Pumps: New Strategy for Morbidly Obese Patients to Get to Heart Transplantation

Published:

28 June 2022

Citation:

Interventional Cardiology Review 2022;17(Suppl 1):25.

APSC Consensus on OSA in CVD Patients

Published:

20 June 2022

Citation:

European Cardiology Review 2022;17:e16.

Evaluation of the Effect of Heart Failure Reversal Therapy on Anthropometric Obesity Parameters in Patients with Chronic Heart Failure: A Retrospective Analysis

Citation:

European Cardiology Review 2020;15:e37.

Recognition, Diagnosis, and Management of Heart Failure with Preserved Ejection Fraction

Citation:

US Cardiology Review 2018;12(1):8–12.